imported raw materials from Kobayashi Pharmaceutical 結果共1筆

Taipei (TVBS News) reports that Taiwan’s Food and Drug Administration (FDA) has taken action after businesses reported using red yeast rice raw materials from Japan’s Kobayashi Pharmaceutical, linked to kidney disease. Preventive measures have been taken, with products removed from shelves. FDA Director-General Wu Hsiu-mei oversees the situation to safeguard consumer safety.